- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: November 2015
- Public Summary Document (PSD) November 2015 PBAC Meeting - PDF
- Public Summary Document (PSD) November 2015 PBAC Meeting - Word
Sorafenib – November 2015
Sorafenib: tablet, 200 mg, Nexavar®
Last updated
18 March 2016